Ancora Advisors’s Pacer BioThreat Strategy ETF VIRS Stock Holding History

Ancora Advisors’s Portfolio VIRS Stock Details VIRS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-203	Closed	-$11K	–	2560
2021 Q4	$11K	Buy	+203	New	+$6.9K	﹤0.01%	1775

Other funds holding VIRS

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Cambridge Investment Research Advisors Fairfield, Iowa $43.3B AUM 29.3% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Ancora Advisors's VIRS Position: Q1 2022 in Review

Ancora Advisors sold out of Pacer BioThreat Strategy ETF (VIRS) in Q1 2022, closing a stake of 203 shares — an estimated $11K sold.

Ancora Advisors first reported a position in VIRS in Q4 2021 and held it in 1 quarter. The position peaked at $11K in Q4 2021. 4 funds tracked by Wall St. Rank hold VIRS as of Q1 2022.

Ancora Advisors reported no remaining Pacer BioThreat Strategy ETF position as of Q1 2022 after selling out during the quarter.
Ancora Advisors sold 203 Pacer BioThreat Strategy ETF shares in Q1 2022, an estimated $11K.
Ancora Advisors first reported a position in Pacer BioThreat Strategy ETF in Q4 2021 and held it in 1 quarter.
Ancora Advisors's Pacer BioThreat Strategy ETF position peaked at $11K in Q4 2021.
4 funds tracked by Wall St. Rank held Pacer BioThreat Strategy ETF as of Q1 2022.

Based on Ancora Advisors's 13F filing for Q1 2022, filed 13 May 2022.